InvestorsHub Logo

ohsaycanyousee82

04/30/23 11:18 AM

#413057 RE: Doc328 #413047

“ I am hoping with Dr. Kin's input and info gleaned from the end of phase 2 study meeting with the FDA they will design a sound P3 properly powered for approval.”

And that’s why you held on to that 1,000 shares?

frrol

04/30/23 11:21 AM

#413059 RE: Doc328 #413047

Bringing on biostat firepower was needed, and it's good to see the company recognized that. It should pay dividends for the future trials.

abew4me

04/30/23 3:24 PM

#413082 RE: Doc328 #413047

Obviously you are fairly certain that the P2b/3 AD trial did not meet both endpoints...based on the data that's been presented to the public (so far).

However, can you play devil's advocate and assume that Dr. Missling is correct that both endpoints have been met...and give us the best possible scenario that would validate Dr. Missling's claim?

Thanks.